These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

545 related items for PubMed ID: 23158430

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2. Saurolactam inhibits osteoclast differentiation and stimulates apoptosis of mature osteoclasts.
    Kim MH, Ryu SY, Choi JS, Min YK, Kim SH.
    J Cell Physiol; 2009 Dec; 221(3):618-28. PubMed ID: 19653230
    [Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4. Neuropeptide FF attenuates RANKL-induced differentiation of macrophage-like cells into osteoclast-like cells.
    Sun Y, Chen X, Chen Z, Ma X, Li D, Shang P, Qian A.
    Arch Oral Biol; 2015 Feb; 60(2):282-92. PubMed ID: 25463906
    [Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6. PTHrP participates in the bone destruction of middle ear cholesteatoma via promoting macrophage differentiation into osteoclasts induced by RANKL.
    Xie S, Jin L, Fu J, Yuan Q, Yin T, Ren J, Liu W.
    Zhong Nan Da Xue Xue Bao Yi Xue Ban; 2024 May 28; 49(5):655-666. PubMed ID: 39174879
    [Abstract] [Full Text] [Related]

  • 7. Inhibitory effect of minocycline on osteoclastogenesis in mouse bone marrow cells.
    Nagasawa T, Arai M, Togari A.
    Arch Oral Biol; 2011 Sep 28; 56(9):924-31. PubMed ID: 21377143
    [Abstract] [Full Text] [Related]

  • 8. Osteoprotegerin influences the bone resorption activity of osteoclasts.
    Fu YX, Gu JH, Zhang YR, Tong XS, Zhao HY, Yuan Y, Liu XZ, Bian JC, Liu ZP.
    Int J Mol Med; 2013 Jun 28; 31(6):1411-7. PubMed ID: 23563320
    [Abstract] [Full Text] [Related]

  • 9. The fungal metabolite (+)-terrein abrogates osteoclast differentiation via suppression of the RANKL signaling pathway through NFATc1.
    Nakagawa S, Omori K, Nakayama M, Mandai H, Yamamoto S, Kobayashi H, Sako H, Sakaida K, Yoshimura H, Ishii S, Ibaragi S, Hirai K, Yamashiro K, Yamamoto T, Suga S, Takashiba S.
    Int Immunopharmacol; 2020 Jun 28; 83():106429. PubMed ID: 32222639
    [Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12. Chlorogenic acid inhibits osteoclast differentiation and bone resorption by down-regulation of receptor activator of nuclear factor kappa-B ligand-induced nuclear factor of activated T cells c1 expression.
    Kwak SC, Lee C, Kim JY, Oh HM, So HS, Lee MS, Rho MC, Oh J.
    Biol Pharm Bull; 2013 Jun 28; 36(11):1779-86. PubMed ID: 23985829
    [Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14. Poligoni Multiflori Radix enhances osteoblast formation and reduces osteoclast differentiation.
    Han SY, Lee KH, Kim YK.
    Int J Mol Med; 2018 Jul 28; 42(1):331-345. PubMed ID: 29620250
    [Abstract] [Full Text] [Related]

  • 15. MCP-1-induced human osteoclast-like cells are tartrate-resistant acid phosphatase, NFATc1, and calcitonin receptor-positive but require receptor activator of NFkappaB ligand for bone resorption.
    Kim MS, Day CJ, Selinger CI, Magno CL, Stephens SR, Morrison NA.
    J Biol Chem; 2006 Jan 13; 281(2):1274-85. PubMed ID: 16280328
    [Abstract] [Full Text] [Related]

  • 16. Trapidil, a platelet-derived growth factor antagonist, inhibits osteoclastogenesis by down-regulating NFATc1 and suppresses bone loss in mice.
    Kim SD, Kim HN, Lee JH, Jin WJ, Hwang SJ, Kim HH, Ha H, Lee ZH.
    Biochem Pharmacol; 2013 Sep 15; 86(6):782-90. PubMed ID: 23928189
    [Abstract] [Full Text] [Related]

  • 17. Orostachys japonicus Suppresses Osteoclast Differentiation by Inhibiting NFATc1 Expression.
    Shim KS, Ha H, Kim T, Lee CJ, Ma JY.
    Am J Chin Med; 2015 Sep 15; 43(5):1013-30. PubMed ID: 26205967
    [Abstract] [Full Text] [Related]

  • 18. Primary human bone marrow adipocytes support TNF-α-induced osteoclast differentiation and function through RANKL expression.
    Goto H, Hozumi A, Osaki M, Fukushima T, Sakamoto K, Yonekura A, Tomita M, Furukawa K, Shindo H, Baba H.
    Cytokine; 2011 Dec 15; 56(3):662-8. PubMed ID: 21963155
    [Abstract] [Full Text] [Related]

  • 19. [Ascorbic acid inhibits the formation and function of osteoclasts from RAW264.7 cells induced by receptor activated nuclear factor kappaB ligand in vitro].
    Xiao XH, Zhou HD, Yuan LQ, Xie H, Liao EY.
    Zhonghua Yi Xue Za Zhi; 2004 Dec 17; 84(24):2102-6. PubMed ID: 15730627
    [Abstract] [Full Text] [Related]

  • 20. Compressive force induces osteoclast differentiation via prostaglandin E(2) production in MC3T3-E1 cells.
    Sanuki R, Shionome C, Kuwabara A, Mitsui N, Koyama Y, Suzuki N, Zhang F, Shimizu N, Maeno M.
    Connect Tissue Res; 2010 Apr 17; 51(2):150-8. PubMed ID: 20001844
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 28.